We investigated a possible relation between prolactin receptor (PRL-R) or IL-2 receptor alpha (IL-2Rα, CD25) expression on circulating T lymphocytes and their apoptosis in patients with breast cancer. The gene discussed is IL2RA; the disease is breast carcinoma.